---
title: "Progesterone - Atrophic Vaginitis"
sidebar: mydoc_sidebar
permalink: db00396-mesh-d059268-1.html
toc: false 
---


Path ID: `DB00396_MESH_D059268_1`
{% include image.html url="images/db00396-mesh-d059268-1.png" file="db00396-mesh-d059268-1.png" alt="db00396-mesh-d059268-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D011374 | Progesterone | Drug |
| UniProt:P06401 | Progesterone receptor | Protein |
| GO:0050847 | Progesterone receptor signaling pathway | BiologicalProcess |
| MESH:D059268 | Atrophic vaginitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Progesterone | INCREASES ACTIVITY OF | Progesterone Receptor |
| Progesterone Receptor | PARTICIPATES IN | Progesterone Receptor Signaling Pathway |
| Progesterone Receptor Signaling Pathway | TREATS | Atrophic Vaginitis |
|---------|-----------|---------|

Comment: Progesterone is often prescribed in combination with estradiol component for atrophic vaginitis.

Reference: 
  - [https://go.drugbank.com/drugs/DB00396#BE0000557](https://go.drugbank.com/drugs/DB00396#BE0000557)
  - [https://www.sciencedirect.com/science/article/abs/pii/S0378512296010870](https://www.sciencedirect.com/science/article/abs/pii/S0378512296010870)
